Lutein improves cell viability and reduces Alu RNA accumulation in hydrogen peroxide challenged retinal pigment epithelial cells (scientific article published on 29 May 2017)

A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8

Q24544001

A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E and beta carotene for age-related cataract and vision loss: AREDS report no. 9

Q24546140

DICER1 loss and Alu RNA induce age-related macular degeneration via the NLRP3 inflammasome and MyD88

Q24621930

Fruits and vegetables that are sources for lutein and zeaxanthin: the macular pigment in human eyes

Q24673347

NLRP3 inflammasome: activation and regulation in age-related macular degeneration

Q26995315

Lutein + Zeaxanthin and Omega-3 Fatty Acids for Age-Related Macular Degeneration

Q28290149

TLR-independent and P2X7-dependent signaling mediate Alu RNA-induced NLRP3 inflammasome activation in geographic atrophy

Q28590969

Age-related macular degeneration--emerging pathogenetic and therapeutic concepts

Q33263472

Why has Nature Chosen Lutein and Zeaxanthin to Protect the Retina?

Q33687586

Lutein, zeaxanthin, and the macular pigment

Q33947513

Double-masked, placebo-controlled, randomized trial of lutein and antioxidant supplementation in the intervention of atrophic age-related macular degeneration: the Veterans LAST study (Lutein Antioxidant Supplementation Trial).

Q33977885

The role of oxidative stress in the pathogenesis of age-related macular degeneration.

Q34060719

Cell models to study regulation of cell transformation in pathologies of retinal pigment epithelium

Q34080190

Hydrogen peroxide in the human body.

Q34099983

Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment

Q34400646

DICER1 deficit induces Alu RNA toxicity in age-related macular degeneration

Q34796058

A potential therapeutic role for P2X7 receptor (P2X7R) antagonists in the treatment of inflammatory diseases

Q35044923

Effects of lutein or lutein in combination with vitamin C on mRNA expression and activity of antioxidant enzymes and status of the antioxidant system in SD rats

Q36149508

Functional importance of Dicer protein in the adaptive cellular response to hypoxia

Q36217312

Cudraflavone C Induces Tumor-Specific Apoptosis in Colorectal Cancer Cells through Inhibition of the Phosphoinositide 3-Kinase (PI3K)-AKT Pathway

Q36255950

Jerantinine A induces tumor-specific cell death through modulation of splicing factor 3b subunit 1 (SF3B1)

Q36280761

Elevated Fundus Autofluorescence in Monkeys Deficient in Lutein, Zeaxanthin, and Omega-3 Fatty Acids

Q36738021

Nutrient supplementation with n3 polyunsaturated fatty acids, lutein, and zeaxanthin decrease A2E accumulation and VEGF expression in the retinas of Ccl2/Cx3cr1-deficient mice on Crb1rd8 background

Q36926292

Lutein and zeaxanthin supplementation reduces photooxidative damage and modulates the expression of inflammation-related genes in retinal pigment epithelial cells

Q37098578

Efficacy of Ethanol Extract of Fructus lycii and Its Constituents Lutein/Zeaxanthin in Protecting Retinal Pigment Epithelium Cells against Oxidative Stress: In Vivo and In Vitro Models of Age-Related Macular Degeneration

Q37218617

Carotenoid derived aldehydes-induced oxidative stress causes apoptotic cell death in human retinal pigment epithelial cells

Q37450470

Genotoxic effects of carotenoid breakdown products in human retinal pigment epithelial cells

Q37485773

Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis.

Q38238059

6-Shogaol inhibits breast and colon cancer cell proliferation through activation of peroxisomal proliferator activated receptor γ (PPARγ).

Q38316069

A protective effect of anthocyanins and xanthophylls on UVB-induced damage in retinal pigment epithelial cells

Q38802196

Mechanisms Underlying the Anti-Inflammatory Effects of Clinacanthus nutans Lindau Extracts: Inhibition of Cytokine Production and Toll-Like Receptor-4 Activation

Q39176750

Zeaxanthin, a retinal carotenoid, protects retinal cells against oxidative stress

Q39859940

P-Glycoprotein expression in human retinal pigment epithelium cell lines

Q40306271

Oxidative stress in ARPE-19 cultures: do melanosomes confer cytoprotection?

Q40342011

Effect of a complex lutein formula in an animal model for light-induced retinal degeneration

Q40390517

Oxidative stress, hypoxia, and autophagy in the neovascular processes of age-related macular degeneration.

Q42413400

Hydrogen peroxide stimulates apoptosis in cultured human retinal pigment epithelial cells

Q43681092

Changes in macular pigment optical density and serum concentrations of its constituent carotenoids following supplemental lutein and zeaxanthin: the LUNA study

Q44212321

Hydrogen peroxide-induced cell death in a human retinal pigment epithelial cell line, ARPE-19.

Q44526629

Improvement of retinal function in early age-related macular degeneration after lutein and zeaxanthin supplementation: a randomized, double-masked, placebo-controlled trial

Q44696848

Toxicity of oxidized beta-carotene to cultured human cells

Q46557286

Randomized, double-blind, placebo-controlled study of zeaxanthin and visual function in patients with atrophic age-related macular degeneration: the Zeaxanthin and Visual Function Study (ZVF) FDA IND #78, 973.

Q50268024

Lutein supplementation over a one-year period in early AMD might have a mild beneficial effect on visual acuity: the CLEAR study.

Q53121765

P433

issue

P407

language of work or name

English

Q1860

P304

page(s)

52-60